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Abstract 
Aim: It is important to develop simple, reliable methods to identify high-risk 
individuals who may benefit from intervention. This study investigated the 
association between the triglyceride to high-density lipoprotein cholesterol (TG/HDL) 
ratio and cardiometabolic risk, cardiorespiratory fitness and physical activity in 
children. Methods: Anthropometric, biochemical parameters, cardiorespiratory 
fitness and accelerometry determined physical activity were assessed in 155 
children (80 girls) from 10 to 14-years-of-age from Bedfordshire, UK. Participants 
were grouped into high and low TG/HDL ratio groups, according to published 
thresholds. MANCOVA and logistic regression were used in the analysis. Results: 
Cardiometabolic risk factor levels were significantly higher in participants with a high 
TG/HDL ratio (p<0.05). The odds of having high waist circumference (OR = 13.99; 
95% CI 2.93, 69.25), elevated systolic blood pressure (5.27; 1.39, 20.01), high non-
HDL cholesterol (19.47; 4.42, 85.81) and ≥2 cardiometabolic risk factors (15.32; 
3.10, 75.79) were higher in participants with a high TG/HDL ratio. The TG/HDL ratio 
values were significantly lower in those with high cardiorespiratory fitness (p = 0.01), 
but there was no association with physical activity. Conclusion: These findings 
support the use of the TG/HDL ratio to identify children with cardiometabolic risk 
factors who may be at risk of developing cardiometabolic disease. 
 
Keywords: cardiometabolic risk; obesity; lipoproteins; blood pressure; metabolic 
syndrome 
 
Key notes 
• Identifying high-risk individual is important and we investigated the association 
between the triglyceride to high-density lipoprotein cholesterol (TG/HDL) ratio 
  
 
and cardiometabolic risk, cardiorespiratory fitness and physical activity in 155 
children. 
• Our study showed that the TG/HDL ratio effectively identified children aged 10 to 
14 years who may be at risk of developing cardiometabolic disease. 
• This simple lipid marker can be used to identify children who may benefit from 
risk-reducing interventions. 
 
 
  
 
Introduction 
There is growing interest in identifying cardiovascular risk factors at an early age as 
obesity (1), impaired glucose metabolism (2) and high blood pressure (3) in 
childhood are associated with increased risk of cardiometabolic disease in 
adulthood. It is important to develop simple and reliable methods that can be used 
in clinical practice and community settings to identify high-risk individuals who may 
benefit from lifestyle interventions. 
Dyslipidemia is predictive of cardiovascular disease in adults and lipoprotein 
ratios have greater predictive value than isolated parameters used independently 
(4). The triglyceride to high-density lipoprotein cholesterol (TG/HDL) ratio identifies 
adults with dyslipidemia, insulin resistance and cardiovascular disease (5, 6). Lipid 
parameters are associated with atherosclerosis in children (7), but the clinical and 
prognostic value of the TG/HDL ratio is unclear. Hannon et al (8) reported a receiver 
operation characteristic (ROC)-generated threshold for the TG/HDL ratio (≥3) 
related to insulin sensitivity in overweight adolescents. To the authors’ knowledge, 
no study has tested the ability of this threshold to identify the presence of 
cardiometabolic risk factors in children. Furthermore, there appears to be no data 
concerning the association of the TG/HDL ratio to cardiorespiratory fitness (CRF) 
and physical activity (PA) in children. This is important as low levels of CRF and PA 
have been linked with adverse cardiometabolic risk in children (9, 10) and such data 
may thus help focus interventions. 
This study therefore investigated the odds of having individual and clustered 
cardiometabolic risk factors using a published ROC-generated TG/HDL ratio 
threshold and explored associations with PA, sedentary time and CRF. 
 
Patients and Methods 
Sample 
  
 
Baseline data was analysed from 155 schoolchildren (80 girls) from 10 to 14-years-
of-age who took part in the Health And Physical Activity Promotion in Youth 
(HAPPY) study. Participants were recruited on a voluntary basis from local schools 
in Bedfordshire, UK. Participants were excluded if they had any contraindications to 
taking part in physical exercise or any known blood borne disease. The study was 
approved by the University of Bedfordshire ethics review board and written informed 
consent was obtained from parents and verbal assent from the children before any 
testing procedures. Informed consent followed the principles outlined in the 
Declaration of Helsinki. 
 
Procedures 
Age in years was recorded as a decimal value for each participant. Ethnicity was 
recorded as white or non-white. Home postal codes were used to generate indices 
of multiple deprivation (IMD) scores, which indicated area-level socio-economic 
status relevant to where the children lived (11). 
Stature and waist circumference at the umbilicus were recorded to the 
nearest 0.5cm using the portable Leicester Height Measure (Seca, Birmingham) 
and an adjustable tape measure (Hoechstmass, Sulzbach, Germany), respectively. 
Body mass and percentage of body fat were recorded to the nearest 0.1kg and 
0.1%, respectively, using the Tanita BC-418® segmental body composition analyzer 
(Tanita Corp., Tokyo). Body mass index (BMI) was calculated using the equation: 
BMI = body mass (kg) ÷ stature2 (m2). UK 1990 reference values were used to 
calculate z-scores for BMI (12). 
Sitting blood pressure was measured (Omron M5-I automated oscillatory 
device, Omron Matsusaka Co. Ltd., Matsusaka, Japan) after the participant had 
rested for five minutes. Three blood pressure readings were obtained and the 
average for the lowest two readings recorded. Fasting blood samples were obtained 
  
 
using a finger prick method and analysed using the Cholestech LDX analyser 
(Cholestech Corp., Hayward, CA.) to provide a valid measure of total cholesterol, 
HDL, triglycerides, and blood glucose levels (13). The TG/HDL ratio was calculated 
using the equation: triglycerides (mg/dL) ÷ HDL (mg/dL). Participants were required 
to have fasted from 9pm the night before measurements were taken. Body 
composition and blood measurements were taken between 8am and 10am. 
To determine CRF, participants completed an age- and sex-specific all-out 
progressive cycle ergometer test to exhaustion using a previously validated protocol 
(14) and this took place a minimum of 90 minutes after a breakfast snack was 
consumed. A total of146 participants met the criteria for a maximal CRF test effort: 
final heart rate ≥185 bpm and subjective observation from the researcher that the 
child could not continue (9). Power output in watts was calculated as being equal to 
W1 + (W2. t/180), where W1 was work rate at fully completed stage, W2 was the work 
rate increment at final incomplete stage and t was time in seconds at the final 
incomplete stage. VO2max was calculated using previously described formulae (10) 
and expressed as mL per kilogram body mass per min (mL/kg/min). 
RT3® triaxial accelerometers (Stayhealthy, Inc., Monrovia, CA.) were used 
to measure seven consecutive days of minute-by-minute habitual PA and to 
determine time spent sedentary at less than 420 counts per minute (cpm) and 
engaged in light (420-1859 cpm), moderate (1860-4109 cpm) and vigorous PA (≥ 
4110 cpm) (15). Time spent in each PA subcomponent was calculated and 
presented as average minutes per day during the monitoring period. Participants 
were included for data analysis if they had worn the accelerometer for a minimum of 
three days (16) and acquired a minimum daily wear time of nine hours for weekdays 
(16) and eight hours for weekend days (17). Valid PA data was provided by 103 
participants. There were no differences in anthropometric, cardiometabolic risk and 
CRF variables between children who did, and did not meet, the accelerometer wear 
time criteria (p>0.05). 
  
 
 
Definition of terms 
A high waist circumference was defined as ≥90th percentile for age and sex 
according to published reference curves (18). In children from 10 to 19-years-of-
age, reference values from the National Cholesterol Education Program’s (NCEP) 
Pediatric Panel Report (19) define a borderline high range for triglyceride 
concentrations as 90-129 mg/dL. Thus, the midpoint value for triglyceride 
concentrations (≥110 mg/dL) was taken as the 90th percentile value for age. The 
NCEP Pediatric Panel Report (19) gives a range of 35-45 mg/dL for borderline low 
HDL levels for all sexes and ages. Therefore, the midpoint of this range (≤40 mg/dL) 
was used as the 10th percentile value to define low HDL. Hypercholesterolaemia 
was defined as total cholesterol ≥200 mg/dL (19). A high non-HDL level was defined 
as ≥120 mg/dL (20) and impaired fasting glucose ≥100 mg/dL (21). High systolic 
and diastolic blood pressure were defined as ≥90th percentile for age, sex, and 
height based on published reference values (22). Values >37.0 mL/kg/min for 
females and >42.1 mL/kg/min for males represented a high level of CRF, while 
values below these thresholds represented low CRF (10). An average accumulation 
of ≥60 minutes per day of moderate-to-vigorous PA (MVPA) represented physically 
active children who met current UK government guidelines, while those who did not 
reach this threshold were considered inactive (23). A high TG/HDL ratio was defined 
as ≥3 (8). 
 
Statistical analysis 
All analyses were completed using SPSS version 19.0 (SPSS Inc., Chicago, IL.). 
Percentage of body fat, waist circumference, triglycerides, and the TG/HDL ratio 
were non-normally distributed and log10 transformed prior to analysis. Moderate 
PA, vigorous PA, and MVPA were non-normally distributed and square root 
transformed prior to analysis. Back transformation of these variables to natural units 
  
 
was applied to allow for meaningful presentation in text and tables. Partial 
correlation analysis was used to explore associations between the TG/HDL ratio, 
CRF, and PA variables after controlling for age, sex, socioeconomic status, and 
ethnicity. MANCOVA compared risk factor levels between participants with a 
TG/HDL ≥3 and those with a TG/HDL <3. Separate ANCOVAs were used to 
compare TG/HDL levels between participants with low and high CRF and between 
physically active and inactive participants. Covariates were age, sex, socioeconomic 
status, and ethnicity. Odds ratios (ORs) and 95% confidence intervals (CI) for 
having individual and clustered (≥2) cardiometabolic risk factors were explored 
using logistic regression. All regression models controlled for age, sex, 
socioeconomic status, and ethnicity. Differences in prevalence of the metabolic 
syndrome according to TG/HDL category was explored using X2. Statistical 
significance was set at p<0.05. 
 
Results 
The prevalence of high waist circumference was 32.9%, elevated systolic blood 
pressure was 14.8%, elevated diastolic blood pressure was 17.4%, impaired fasting 
glucose was 16.1%, hypercholesterolemia was 5.2%, low HDL was 12.9%, high 
non-HDL was 18.7% and hypertriglyceridemia was 15.5%. We found that 61.9% of 
the sample had one or more of the preceding risk factors and 37.4% had two or 
more. Metabolic syndrome was identified in 14.8% of participants and a high 
TG/HDL ratio (≥3) in 8.4%. Of the 146 participants with valid CRF data, the 
prevalence of low CRF was 36.3%. Of the 103 participants with valid PA data, 
24.3% accumulated ≥60 minutes per day of MVPA. 
Comparison of adiposity and cardiometabolic risk factor levels between 
participants with low and high TG/HDL ratios are presented in Table 1. The 
adiposity variables zBMI (sample mean -0.15 ± 1.31), percentage of body fat (20.4 ± 
6.5 %) and waist circumference (66.1 ± 9.6 cm) were all significantly higher in those 
  
 
with a TG/HDL ratio ≥3, as was systolic blood pressure (108.8 ± 9.5 mmHg) and 
non-HDL (96.62 ± 24.79 mg/dL). Blood glucose (91.45 ± 8.69 mg/dL), total 
cholesterol (151.66 ± 25.73 mg/dL), and diastolic blood pressure (68.6 ± 7.1 mmHg) 
did not differ significantly between the TG/HDL ratio groups. 
A small-moderate strength correlation was observed between CRF (sample 
mean 42.43 ± 9.66 mL/kg/min) and the TG/HDL ratio (r = -0.21, p = 0.01). 
Participants with low CRF had significantly higher TG/HDL ratios compared to those 
with high CRF (1.91 ± 1.77 vs. 1.27 ± 0.81, respectively, F=8.15, p=0.01). Time 
spent sedentary (498.78 ± 91.0 min/d) and in light PA (184.3 ± 48.2 min/d), 
moderate PA (42.8 ± 24.0 min/d), vigorous PA (2.7 ± 3.8 min/d) and MVPA (45.7 ± 
25.4 min/d) were not significantly correlated with the TG/HDL ratio (p>0.05). There 
was no difference in the TG/HDL ratio between physically active and inactive 
participants (1.45 ± 0.89 vs. 1.57 ± 1.59, respectively, F=0.002, p=0.97). 
The multivariate adjusted ORs (and 95% CIs) for having adverse 
cardiometabolic risk factor levels across the TG/HDL ratio groups are presented in 
Table 2. Participants with a high TG/HDL ratio had significantly higher odds of 
having a high waist circumference, elevated systolic blood pressure, high non-HDL, 
and ≥2 risk factors compared to those with a normal TG/HDL ratio. Although 
expected, the odds of having low HDL (OR = 22.12; 95% CI 5.35, 91.45), 
hypertriglyceridemia (224.47; 19.33, 2606.57) and metabolic syndrome (48.01; 9.52, 
242.10) were higher in those with a high TG/HDL ratio. When further adjusting the 
logistic regression models for percentage of body fat, all the above associations 
remained significant. Metabolic syndrome was present in 76.9% of participants with 
a high TG/HDL ratio compared to 9.2% of participants who did not have a high 
TG/HDL (p<0.001). 
  
Discussion 
  
 
The primary finding of this study was an association between a high TG/HDL ratio 
and adverse cardiometabolic risk profiles in children. Such lipid markers are 
standardised and easily obtained in clinical and non-clinical settings and, in the 
context of these findings, highlights the potential application of this lipid ratio to 
identify children who could be targeted for intervention. 
 Children with a TG/HDL ratio of ≥3 had higher fatness and cardiometabolic 
risk factor levels. When stratified into tertiles, increased levels of risk factors, arterial 
stiffness, and preclinical signs of liver and cardiac abnormalities were observed 
across TG/HDL groups in children (24-26). However, this method of stratification is 
only meaningful to the sample it is testing and analyses using ROC-generated 
thresholds are needed to identify clinically relevant cut points. In overweight 
children, an ROC-generated TG/HDL ratio threshold of ≥3 was identified in relation 
to insulin sensitivity and children with values above this threshold presented higher 
visceral fat and total cholesterol levels and lower adiponectin levels (8). An ROC-
generated threshold of ≥3 was also previously identified in children in relation to 
insulin resistance and was linked with increased blood pressure, blood glucose, and 
lipids (27). 
Although these data provide evidence of linear associations between the 
TG/HDL ratio and risk factors, the current study additionally provides evidence 
supporting the use of an ROC-generated TG/HDL threshold to detect the presence 
of cardiometabolic disorders according to proposed health-related thresholds. The 
odds of having individual and clustered risk factors were higher in those with a 
TG/HDL ratio ≥3, independent of adiposity. A longitudinal study over 13 years 
reported that adolescents with an elevated TG/HDL ratio were more likely to 
express a proatherogenic lipid profile in adulthood (28). Given the growing amount 
of cross-sectional data supporting the clinical usefulness of the TG/HDL ratio (8, 24-
27), additional longitudinal studies may further support the use of this lipoprotein 
ratio to identify those at risk of cardiometabolic disease, or dyslipidemia in particular, 
  
 
and replace high triglycerides and low HDL in the definition of the metabolic 
syndrome, as suggested previously (24). 
 This is the first study to explore the association between PA, sedentary time, 
and CRF and the TG/HDL ratio. There was no relationship between the TG/HDL 
ratio and any PA or sedentary variable. Furthermore, TG/HDL ratio levels did not 
differ between active and inactive children. Although associations between 
triglyceride levels and PA in children have been observed previously (9), the same 
is not apparent for HDL (9) and this may explain the lack of association between PA 
and the TG/HDL ratio. PA has been linked with other cardiometabolic risk factors in 
children (9), though, and the potential health benefits of this behaviour should thus 
not be neglected. 
The TG/HDL ratio was significantly lower in those with high compared to low 
CRF. This is an important finding given the literature that has reported decreases in 
childhood CRF in recent years (29) and that CRF during youth is related to 
cardiometabolic risk profile in adulthood (30). Previous studies have observed 
associations between CRF, HDL and triglycerides (9) and reduced clustered 
cardiometabolic risk in children with high CRF (10). It may thus be desirable to focus 
attention on increasing CRF in an attempt to reduce cardiometabolic disease risk. 
 Limitations of this study include the cross-sectional design and, thus, the 
direction of causality cannot be determined. It is possible the strength of association 
between the TG/HDL ratio, cardiometabolic risk, and CRF may differ when 
employing alternative proposed thresholds. However, it is unknown which 
thresholds present the greatest risk for future adverse health outcomes. Due to the 
small sample size, it was not possible to produce an ROC-generated cut point for 
the TG/HDL ratio in this study. The effects of maturation on cardiometabolic risk 
were not controlled for, however, previous research has shown increased 
cardiometabolic risk in children with a TG/HDL ratio threshold of ≥3 regardless of 
pubertal stage (27). Other potentially confounding factors that were not accounted 
  
 
for include pregnancy, oral contraceptive pills, tobacco use, and presence of type 1 
or type 2 diabetes. 
Children who achieved ≥185 bpm when terminating the CRF test were 
included for analysis, yet this may not be a maximal effort for all children and the 
mean values for CRF may be slightly underestimated. However, it is unlikely that 
this will affect the observed associations between CRF and the TG/HDL ratio. 
Measuring PA using accelerometry presents another limitation. There is no 
standardised method for reduction of accelerometry data and the variations in which 
PA data is measured and expressed can affect outcome variables and conclusions 
within studies.  
In conclusion, the TG/HDL ratio was associated with cardiometabolic risk in 
this sample of children and may thus be suitable for identifying those who may 
benefit from health promotion interventions. Longitudinal data that determine 
whether a high TG/HDL ratio in childhood is linked with disease risk in adulthood 
are required to confirm the efficacy of this lipoprotein ratio as a screening tool. 
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Table 1 Associations between TG/HDL level and cardiometabolic risk factors (N = 155). Covariates entered into the model were age, sex, 
socioeconomic status, and ethnicity. 
 TG/HDL <3 (N = 142) TG/HDL ≥3 (N = 13) F value P value 
Height (cm) 150.29 (9.85) 158.71 (13.24) 7.42 0.01 
Weight (kg) 40.9 (11.3) 54.6 (11.5) 15.98 <0.001 
z-BMI -0.26 (1.28) 1.21 (0.82) 13.51 <0.001 
Percentage of body fat 20.0 (6.5) 25.1 (4.8) 10.10 0.002 
Waist (cm) 65.3 (9.3) 76.0 (7.5) 14.20 <0.001 
Systolic BP (mmHg) 108.3 (8.8) 115.2 (14.6) 4.32 0.04 
Diastolic BP (mmHg) 68.3 (7.0) 71.7 (6.6) 2.31 0.13 
Blood glucose (mg/dL) 91.11 (8.71) 95.46 (7.59) 2.91 0.09 
Total cholesterol (mg/dL) 150.93 (26.19) 160.25 (18.23) 1.85 0.18 
Non-HDL (mg/dL) 94.28 (23.78) 124.07 (20.03) 20.09 <0.001 
TG, triglycerides; HDL, high-density lipoprotein cholesterol; BMI, body mass index; BP, blood pressure. Data reported as mean (SD). 
  
 
Table 2 Multivariate-adjusted odds ratios (and 95% CIs) for cardiometabolic 
disorders across the TG/HDL ratio groups (TG/HDL <3 = reference group) 
 Odds ratio (95% CI) P value 
High waist circumference1 13.99 (2.93, 69.25) 0.001 
Elevated systolic BP2 5.27 (1.39, 20.01) 0.02 
Elevated diastolic BP2 1.64 (0.37, 7.30) 0.52 
Impaired fasting glucose3 1.87 (0.45, 7.76) 0.39 
Hypercholesterolaemia4 0.00 (0.00, 0.00) 1.00 
High non-HDL cholesterol5 19.47 (4.42, 85.81) <0.001 
≥2 risk factors6 15.32 (3.10, 75.79) 0.001 
All models adjusted for age, sex, socioeconomic status, and ethnicity. TG, 
triglycerides; HDL, high-density lipoprotein cholesterol; BP, blood pressure; 1≥90th 
percentile for age and sex; 2≥90th percentile for age, sex and height; 3≥100 mg/dL; 
4≥200 mg/dL; 5≥120 mg/dL; 6≥2 of the following risk factors: high waist 
circumference, elevated systolic BP, elevated diastolic BP, high non-HDL 
cholesterol, and impaired fasting glucose. 
 
